| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Institute of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK
Correspondence
Christopher J. McCormick
cjm{at}soton.ac.uk
Hyperphosphorylation of NS5A is thought to play a key role in controlling hepatitis C virus (HCV) RNA replication. Using a tetracycline-regulable baculovirus delivery system to introduce non-culture-adapted HCV replicons into HepG2 cells, we found that a point mutation in the active site of the viral polymerase, NS5B, led to an increase in NS5A hyperphosphorylation. Although replicon transcripts lacking elements downstream of NS5A also had altered NS5A hyperphosphorylation, this did not explain the changes resulting from polymerase inactivation. Instead, two additional findings may be related to the link between polymerase activity and NS5A hyperphosphorylation. Firstly, we found that disabling polymerase activity, either by targeted mutation of the polymerase active site or by use of a synthetic inhibitor, stimulated translation from the replicon transcript. Secondly, when the rate of translation of non-structural proteins from replicon transcripts was reduced by use of a defective encephalomyocarditis virus internal ribosome entry site, there was a substantial decrease in NS5A hyperphosphorylation, but this was not observed when non-structural protein expression was reduced by simply lowering replicon transcript levels using tetracycline. Therefore, one possibility is that the point mutation within the active site of NS5B causes an increase in NS5A hyperphosphorylation because of an increase in translation from each viral transcript. These findings represent the first demonstration that NS5A hyperphosphorylation can be modulated without use of kinase inhibitors or mutations within non-structural proteins and, as such, provide an insight into a possible means by which HCV replication is controlled during a natural infection.
Present address: Molecular Microbiology, University of Southampton, Southampton General Hospital, Southampton SO16 6YD, UK.
This article has been cited by other articles:
|
|
 |
|
  M. Hughes, S. Griffin, and M. Harris Domain III of NS5A contributes to both RNA replication and assembly of hepatitis C virus particles J. Gen. Virol., June 1, 2009; 90(6): 1329 - 1334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Adair, A. H. Patel, L. Corless, S. Griffin, D. J. Rowlands, and C. J. McCormick Expression of hepatitis C virus (HCV) structural proteins in trans facilitates encapsidation and transmission of HCV subgenomic RNA J. Gen. Virol., April 1, 2009; 90(4): 833 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Zhang, D. Harris, and V. N. Pandey The FUSE Binding Protein Is a Cellular Factor Required for Efficient Replication of Hepatitis C Virus J. Virol., June 15, 2008; 82(12): 5761 - 5773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. K. Ward, C. J. McCormick, I. N. Clarke, O. Salim, C. E. Wobus, L. B. Thackray, H. W. Virgin IV, and P. R. Lambden Recovery of infectious murine norovirus using pol II-driven expression of full-length cDNA PNAS, June 26, 2007; 104(26): 11050 - 11055. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Jones, S. N. Gretton, J. McLauchlan, and P. Targett-Adams Mobility analysis of an NS5A-GFP fusion protein in cells actively replicating hepatitis C virus subgenomic RNA J. Gen. Virol., February 1, 2007; 88(2): 470 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Quintavalle, S. Sambucini, C. Di Pietro, R. De Francesco, and P. Neddermann The {alpha} Isoform of Protein Kinase CKI Is Responsible for Hepatitis C Virus NS5A Hyperphosphorylation J. Virol., November 15, 2006; 80(22): 11305 - 11312. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
